Dr. Travis recalls the available treatments for patients diagnosed with mutliple sclerosis (MS) and describes multiple sclerosis disease modification medications.
My name is Lori Travis. I am a neurologist with a special interest in MS. I have a practice in neurology here in Phoenix and I went to med school at the University of Arizona. I did my neurology residency at the Mayo Clinic and was chief resident in neurology during my senior year there, and I participate in clinical trials for MS research.
There are several treatments available, the most common are the interferons, which would include Betaseron, Extavia®, Avonex, Rebif, and then Copaxone®, and then Tysabri is also available as is Novantrone.
What I usually describe to new patients is that MS disease modification is a chance to really be proactive and to help reduce your risk of having another MS attack. So it’s a medication you take frequently, whether it’s daily or once a week, that allows you to help take control of your illness.
About Dr. Lori Travis, M.D.:
Dr. Travis is a graduate of the University of Arizona Medical School. She completed her neurology residency at The Mayo Clinic in Rochester, Minnesota where she was elected Chief Resident. Dr. Travis is board certified by the American Board of Psychiatry and Neurology. She is currently on faculty at the University of Arizona as a Clinical Assistant Professor of Neurology.